Yi and colleagues used new methylation-on-bead technology with quantitative MSP to specifically screen serum circulating free DNA (cfDNA) for promoter methylation changes in the BNC1 and ADAMTS1 loci—two genes that were verified to be hypermethylated in pancreatic cancer [49]. Here, ADAMTS1 is linked to pancreatic neoplasm.